Bactiguard Holding AB

As of June 30, 2026, Bactiguard Holding AB carries a market capitalization of 553.69M, placing it among publicly traded companies globally. Its enterprise value stands at 667.26M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Bactiguard Holding AB's next confirmed earnings release is scheduled for October 22, 2026.

As of June 30, 2026, Bactiguard Holding AB has 35.04M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 2.66, and the price-to-book ratio stands at 1.82.

As of June 30, 2026, Bactiguard Holding AB trades at an EV/EBITDA multiple of 38.77 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.21 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 667.26M versus a market cap of 553.69M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Bactiguard Holding AB maintains a current ratio of 1.65, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 51.60, indicating elevated leverage, while an interest coverage ratio of 1.99 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Bactiguard Holding AB posted a negative return on equity (ROE) of -3.01, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -1.70, reflecting losses generated across the asset base. The company generates approximately 1.27M in revenue per employee across its workforce of 163.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.10 indicates how many times Bactiguard Holding AB sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Bactiguard Holding AB recorded an income tax benefit of -5.74M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -15.10M and -9.36M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Bactiguard Holding AB's stock has declined approximately 2.77% over the past 52 weeks. The 50-day moving average sits at 15.72, while the 200-day moving average is 16.26.

Over the twelve months ended June 30, 2026, Bactiguard Holding AB generated 207.86M in revenue and converted that into -9.36M in net income, yielding earnings per share of -0.27. EBITDA reached 17.21M, while operating income came in at -9.69M.

As of June 30, 2026, Bactiguard Holding AB holds 43.52M in cash and equivalents against 157.09M in total debt, resulting in a net debt position of 75.93M. Total book value stands at 304.45M, with working capital of 45.74M providing operational flexibility.

Bactiguard Holding AB produced 18.43M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -4.66M in capital expenditures, free cash flow totaled 13.77M - equivalent to 0.39 per share.

Over the twelve months ended June 30, 2026, Bactiguard Holding AB posted a gross margin of 87.26, reflecting its pricing power and cost economics. The operating margin of -4.66 and net profit margin of -4.50 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 2.49, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 1.85, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Bactiguard Holding AB shareholders.

As of June 30, 2026, Bactiguard Holding AB has an Altman Z-Score of -1.26, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.